Literature DB >> 20331378

Large-scale candidate gene analysis of spontaneous clearance of hepatitis C virus.

Timothy L Mosbruger1, Priya Duggal, James J Goedert, Gregory D Kirk, W Keith Hoots, Leslie H Tobler, Michael Busch, Marion G Peters, Hugo R Rosen, David L Thomas, Chloe L Thio.   

Abstract

Human genetic variation is a determinant of recovery from acute hepatitis C virus (HCV) infection; however, to date, single-nucleotide polymorphisms (SNPs) in only a limited number of genes have been studied with respect to HCV clearance. We determined whether SNPs in 112 selected immune response genes are important for HCV clearance, by genotyping 1536 SNPs in a cohort of 343 persons with natural HCV clearance and 547 persons with HCV persistence. PLINK (version 1.05) and Haploview (version 4.1) software packages were used to perform association, permutation, and haplotype analyses stratified by African American and European American race. Of the 1536 SNPs tested, 1426 (92.8%) were successfully genotyped. In African Americans, we identified 18 SNPs located in 11 gene regions that were associated with HCV infection outcome (empirical P value, < .01). In European Americans, there were 20 SNPs located in 8 gene regions associated with HCV infection outcome. Four of the gene regions studied (TNFSF18, TANK, HAVCR1, and IL18BP) contained SNPs for which the empirical P value was <.01 in both of the race groups. In this large-scale analysis of 1426 genotyped SNPs in 112 candidate genes, we identified 4 gene regions that are likely candidates for a role in HCV clearance or persistence in both African Americans and European Americans.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20331378      PMCID: PMC2853721          DOI: 10.1086/651606

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  31 in total

1.  Immunology: hepatitis A virus link to atopic disease.

Authors:  Jennifer J McIntire; Sarah E Umetsu; Claudia Macaubas; Elizabeth G Hoyte; Cengiz Cinnioglu; Luigi L Cavalli-Sforza; Gregory S Barsh; Joachim F Hallmayer; Peter A Underhill; Neil J Risch; Gordon J Freeman; Rosemarie H DeKruyff; Dale T Umetsu
Journal:  Nature       Date:  2003-10-09       Impact factor: 49.962

2.  The natural history of hepatitis C virus infection: host, viral, and environmental factors.

Authors:  D L Thomas; J Astemborski; R M Rai; F A Anania; M Schaeffer; N Galai; K Nolt; K E Nelson; S A Strathdee; L Johnson; O Laeyendecker; J Boitnott; L E Wilson; D Vlahov
Journal:  JAMA       Date:  2000-07-26       Impact factor: 56.272

3.  Racial differences in HLA class II associations with hepatitis C virus outcomes.

Authors:  C L Thio; D L Thomas; J J Goedert; D Vlahov; K E Nelson; M W Hilgartner; S J O'Brien; P Karacki; D Marti; J Astemborski; M Carrington
Journal:  J Infect Dis       Date:  2001-05-30       Impact factor: 5.226

4.  The natural course of hepatitis C virus infection after 22 years in a unique homogenous cohort: spontaneous viral clearance and chronic HCV infection.

Authors:  S Barrett; J Goh; B Coughlan; E Ryan; S Stewart; A Cockram; J C O'Keane; J Crowe
Journal:  Gut       Date:  2001-09       Impact factor: 23.059

5.  HLA-Cw*04 and hepatitis C virus persistence.

Authors:  Chloe L Thio; Xiaojiang Gao; James J Goedert; David Vlahov; Kenrad E Nelson; Margaret W Hilgartner; Stephen J O'Brien; Peter Karacki; Jacquie Astemborski; Mary Carrington; David L Thomas
Journal:  J Virol       Date:  2002-05       Impact factor: 5.103

6.  Modulation of retinoid signaling by a cytoplasmic viral protein via sequestration of Sp110b, a potent transcriptional corepressor of retinoic acid receptor, from the nucleus.

Authors:  Koichi Watashi; Makoto Hijikata; Ayako Tagawa; Takahiro Doi; Hiroyuki Marusawa; Kunitada Shimotohno
Journal:  Mol Cell Biol       Date:  2003-11       Impact factor: 4.272

7.  Association of low-density lipoprotein receptor polymorphisms and outcome of hepatitis C infection.

Authors:  B J W Hennig; S Hellier; A J Frodsham; L Zhang; P Klenerman; S Knapp; M Wright; H C Thomas; M Thursz; A V S Hill
Journal:  Genes Immun       Date:  2002-09       Impact factor: 2.676

8.  Polymorphisms in interferon-induced genes and the outcome of hepatitis C virus infection: roles of MxA, OAS-1 and PKR.

Authors:  S Knapp; L J Yee; A J Frodsham; B J W Hennig; S Hellier; L Zhang; M Wright; M Chiaramonte; M Graves; H C Thomas; A V S Hill; M R Thursz
Journal:  Genes Immun       Date:  2003-09       Impact factor: 2.676

9.  Production of interleukin-18 and interleukin-12 in patients suffering from chronic hepatitis C virus infection before antiviral therapy.

Authors:  E Schvoerer; M C Navas; C Thumann; A Fuchs; N Meyer; F Habersetzer; F Stoll-Keller
Journal:  J Med Virol       Date:  2003-08       Impact factor: 2.327

10.  Genetic variation in IL28B and spontaneous clearance of hepatitis C virus.

Authors:  David L Thomas; Chloe L Thio; Maureen P Martin; Ying Qi; Dongliang Ge; Colm O'Huigin; Judith Kidd; Kenneth Kidd; Salim I Khakoo; Graeme Alexander; James J Goedert; Gregory D Kirk; Sharyne M Donfield; Hugo R Rosen; Leslie H Tobler; Michael P Busch; John G McHutchison; David B Goldstein; Mary Carrington
Journal:  Nature       Date:  2009-10-08       Impact factor: 49.962

View more
  32 in total

Review 1.  Host genetic basis for hepatitis C virus clearance: a role for blood collection centers.

Authors:  Suganya Selvarajah; Leslie H Tobler; Graham Simmons; Michael P Busch
Journal:  Curr Opin Hematol       Date:  2010-11       Impact factor: 3.284

2.  Interleukin 6 promoter polymorphisms influence the outcome of chronic hepatitis C.

Authors:  Annarosa Cussigh; Edmondo Falleti; Carlo Fabris; Davide Bitetto; Sara Cmet; Elisabetta Fontanini; Sara Bignulin; Ezio Fornasiere; Elisa Fumolo; Rosalba Minisini; Mario Pirisi; Pierluigi Toniutto
Journal:  Immunogenetics       Date:  2010-11-12       Impact factor: 2.846

3.  Variants in HAVCR1 gene region contribute to hepatitis C persistence in African Americans.

Authors:  Genevieve Wojcik; Rachel Latanich; Tim Mosbruger; Jacquie Astemborski; Gregory D Kirk; Shruti H Mehta; James J Goedert; Arthur Y Kim; Eric C Seaberg; Michael Busch; David L Thomas; Priya Duggal; Chloe L Thio
Journal:  J Infect Dis       Date:  2013-08-20       Impact factor: 5.226

4.  Association of low-density lipoprotein receptor genotypes with hepatitis C viral load.

Authors:  A Caruz; K Neukam; A Rivero-Juárez; R Herrero; L M Real; A Camacho; P Barreiro; P Labarga; A Rivero; J A Pineda
Journal:  Genes Immun       Date:  2013-10-31       Impact factor: 2.676

5.  High plasma interleukin-18 levels mark the acute phase of hepatitis C virus infection.

Authors:  Michael A Chattergoon; Jordana S Levine; Rachel Latanich; William O Osburn; David L Thomas; Andrea L Cox
Journal:  J Infect Dis       Date:  2011-10-07       Impact factor: 5.226

6.  IL28B genotype effects during early treatment with peginterferon and ribavirin in difficult-to-treat hepatitis C virus infection.

Authors:  John Scott; Sarah Holte; Thomas Urban; Caitlin Burgess; Erica Coppel; Chia Wang; Larry Corey; John McHutchison; David Goldstein
Journal:  J Infect Dis       Date:  2011-08-01       Impact factor: 5.226

7.  Altered expression of SHIP, a Toll-like receptor pathway inhibitor, is associated with the severity of liver fibrosis in chronic hepatitis C virus infection.

Authors:  Antonios Katsounas; Martin Trippler; Shyam Kottilil; Richard A Lempicki; Guido Gerken; Joerg F Schlaak
Journal:  J Infect Dis       Date:  2011-10-15       Impact factor: 5.226

8.  Polymorphisms in EGFR and IL28B are associated with spontaneous clearance in an HCV-infected Iranian population.

Authors:  R Carapito; H Poustchi; M Kwemou; M Untrau; A H Sharifi; S Merat; A Haj-Sheykholeslami; H Jabbari; S Esmaili; S Michel; J Toussaint; M Le Gentil; A Ansari-Moghaddam; M Radosavljevic; A Etemadi; P Georgel; R Malekzadeh; S Bahram
Journal:  Genes Immun       Date:  2015-09-17       Impact factor: 2.676

Review 9.  Genetic variants at the IFNL3 locus and their association with hepatitis C virus infections reveal novel insights into host-virus interactions.

Authors:  Sreedhar Chinnaswamy
Journal:  J Interferon Cytokine Res       Date:  2014-02-20       Impact factor: 2.607

10.  Differentially regulated gene expression associated with hepatitis C virus clearance.

Authors:  Carolyn Z Grimes; Lu-Yu Hwang; Peng Wei; Dimpy P Shah; Kelly A Volcik; Eric L Brown
Journal:  J Gen Virol       Date:  2012-11-14       Impact factor: 3.891

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.